16 filings · most recent first
FOLD 8-K Filings
Biomarin To Acquire Amicus Therapeutics In 48 Billion Deal
Amicus Therapeutics Reports Strong Q3 2025 Financial Results And Provides
Amicus Therapeutics Reports Q2 2025 Financial Results And Corporate Updates
Annual Meeting Voting Results Announced By Amicus Therapeutics Inc
Amicus Therapeutics Reports Q1 2025 Financial Results And Updates Guidance
Amicus Therapeutics Licenses Dmx200 From Dimerix For Fsgs Treatment In The Us
Amicus Therapeutics Inc Files Opinion On Share Legality
Amicus Therapeutics Reports Fullyear 2024 Results And Provides 2025 Guidance
Amicus Therapeutics Announces 2024 Revenue And 2025 Outlook
Amicus Therapeutics Announces Third Quarter 2024 Financial Results And
Amicus Therapeutics Resolves Patent Litigation With Teva
Amicus Therapeutics Reports Strong Q2 2024 Results And Raises Fullyear Guidance
Amicus Therapeutics Inc Announces Annual Meeting Outcomes
Amicus Therapeutics Reports Strong Q1 2024 Results And Raises Fullyear Guidance
Amicus Therapeutics Reports 2023 Financial Results And Provides 2024 Guidance
Amicus Therapeutics Announces Preliminary 2023 Revenue And 2024 Outlook